StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Ir stagezero

<< Previous

Bullboard Posts

Next >>

Post by jp1989on Jul 21, 2021 1:34am

386 Views

Post# 33580047

Ir stagezero

I wrote to Rebecca today. why doesn't the company seem to care about the share price?,......... ...... Thank you for your email. Of course, we care about the share price. However, we care about the business and are focusing on the business not just promotional pumping of the share price. Rebecca

<< Previous

Bullboard Posts

Next >>

Cross border trading in Canada and Australia